There is new research that shows nondiabetic users of weight-loss drugs like Ozempic and Wegovy have an increased risk of pancreatitis, bowel obstruction and stomach paralysis. NBC’s Stephanie Gosk reports for TODAY, and Dr. Tara Narula joins with analysis.
Comments
(・.・;)
There's nothing here…